GILD · Categories · Downgrades
GILD - Analyst downgrades
Gilead Sciences Inc. (GILD) analyst downgrades - real-time wire coverage filtered to Downgrades only.
Recent Downgrades for GILD
- Gilead Sciences downgraded by Maxim GroupMaxim Group downgraded Gilead Sciences from Buy to Hold
- Gilead Sciences downgraded by Truist with a new price targetTruist downgraded Gilead Sciences from Buy to Hold and set a new price target of $82.00 from $91.00 previously
- Gilead Sciences downgraded by RBC Capital Mkts with a new price targetRBC Capital Mkts downgraded Gilead Sciences from Outperform to Sector Perform and set a new price target of $87.00
- Gilead Sciences downgraded by DZ Bank with a new price targetDZ Bank downgraded Gilead Sciences from Buy to Hold and set a new price target of $90.00
- Gilead Sciences downgraded by BMO Capital with a new price targetBMO Capital downgraded Gilead Sciences from Outperform to Market Perform and set a new price target of $65.00 from $75.00 previously
- Gilead Sciences downgraded by Morgan Stanley with a new price targetMorgan Stanley downgraded Gilead Sciences from Overweight to Equal-Weight and set a new price target of $74.00 from $84.00 previously